Found 0 matching trials
Trastuzumab & Pertuzumab Followed by T-DM1 in MBC PHASE2 In HER2-positive metastatic breast cancer, trastuzumab based treatment is t...
Show More Location
Hopital Sud - Amiens
Learn More & Join Trial
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial PHASE3 This phase III trial compares the effect of usual treatment with trastuzuma...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer PHASE2 The purpose of this trial is to evaluate efficacy and toxicity of either th...
Show More Status
Active Not Recruiting
Location
Dept. of Oncology, Örebro University Hospital
Learn More & Join Trial
An Observational Study of Kadcyla Safety in Breast Cancer N/A This is a phase IV, prospective, multicenter, non-interventional study (reg...
Show More Location
Inje University Busan Paik Hospital
Learn More & Join Trial
A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America N/A A Prospective, Multicenter, Non-Interventional Study of Primary Data Collec...
Show More Location
Instituto Alexander Fleming
Learn More & Join Trial
A Study of Trastuzumab Emtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer PHASE3 This is a Phase III, randomized, multicenter, international, 2-arm, open-la...
Show More Location
Multiple Locations
Learn More & Join Trial
ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer PHASE1 The goal of this clinical trial is to test ELVN-002 in people with cancers ...
Show More Status
Active Not Recruiting
Location
University of Colorado - Anschutz Medical Campus - PPDS
Learn More & Join Trial
A Study of BL-M07D1 Versus T-DM1 in the Adjuvant Treatment of HER2-positive Breast Cancer With Residual Invasive Cancer After Neoadjuvant Therapy PHASE3 This trial is a registered phase III, randomized, open-label, multicenter s...
Show More Location
Jiangsu Province Hospital
Learn More & Join Trial
TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery PHASE2 This phase II trial studies how well TPIV100 and sargramostim work in treat...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial
Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers PHASE2 The purpose of this study is to find out what effects, a drug called ado-tr...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial